Metabolic and inflammatory faecal markers in collagenous colitis

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 7, 2007, Pages 567-574

  Wildt, Signe ^a   Nordgaard Lassen, Inge ^a   Bendtsen, Flemming ^a   Rumessen, Jüri J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Calprotectin; Collagenous colitis; Lactoferrin; Short chain fatty acids

Indexed keywords

BIOCHEMICAL MARKER; CALPROTECTIN; LACTOFERRIN; SHORT CHAIN FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGENOUS COLITIS; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; INCUBATION TIME; LATEX AGGLUTINATION TEST; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COLITIS, COLLAGENOUS; FATTY ACIDS, VOLATILE; FECES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LACTOFERRIN; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 34250166515     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328058ed76     Document Type: Article

References (43)

1. Offner FA, Jao RV, Lewin KJ, Havelec L, Weinstein WM. Collagenous colitis: a study of the distribution of morphological abnormalities and their histological detection. Hum Pathol 1999; 30:451-457.
2. Jessurun J, Yardley JH, Giardiello FM, Hamilton SR, Bayless TM. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol 1987; 18:839-848.
3. Nishida Y, Murase K, Isomoto H, Furusu H, Mizuta Y, Riddell RH, et al. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease. Hepatogastroenterology 2002; 49:678-682.
4. Wildt S, Munck LK, Vinter-Jensen L, Hansen BF, Nordgaard-Lassen I, Christensen S, et al. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis. Inflamm Bowel Dis 2006; 12:401.
5. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol 2002; 97:794-802.
6. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34:50-54.
7. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47:506-513.
8. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98:1309-1314.
9. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992; 30:1238-1242.
10. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003; 35:642-647.
11. Berstad A, Arslan G, Folvik G. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Scand J Gastroenterol 2000; 35:64-69.
12. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80:252-267.
13. Yong WH, Mattia AR, Ferraro MJ. Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol 1994; 32:1360-1361.
14. Fine KD, Ogunji F, George J, Niehaus MD, Guerrant RL. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. Am J Gastroenterol 1998; 93:1300-1305.
15. Parsi MA, Shen B, Achkar JP, Remzi FF, Goldblum JR, Boone J, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology 2004; 126:1280-1286.
16. Johne B, Fagerhol M, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andersen CF, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. J Clin Pathol Mol Pathol 1997; 50:113-123.
17. Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005; 54:364-368.
18. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997; 58:176-180.
19. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999; 45:362-366.
20. Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, et al. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol 2000; 95:2831-2837.
21. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123:450-460.
22. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 1998; 12:499-507.
23. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70:443-459.
24. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med 1989; 320:23-28.
25. Clausen MR, Bonnén H, Tvede M, Mortensen PB. Colonic fermentation of dietary fibre to short chain fatty acids is decreased in antibiotic- associated diarrhoea. Gastroenterology 1991; 101:1497-1504.
26. Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctol 2001; 5:163-164.
27. Nordgaard-Andersen I, Clausen MR, Mortensen PB. Short-chain fatty acids, lactate, and ammonia in ileorectal and ileal pouch contents: a model of cecal fermentation. J Parenter Enteral Nutr 1993; 17:324-331.
28. Husebye E, Ton H, Johne B. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm. Am J Gastroenterol 2001; 96:2683-2687.
29. Weaver GA, Krause JA, Miller TL, Wolin MJ. Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer [Abstract]. Gut 1988; 29:1539-1543.
30. Tøn H, Brandsnes Ø, Dale S, Holtlund J, Skuibina E, Schjønsby H, et al. Improved assay for fecal calprotectin. Clin Chim Acta 2000; 292:41-54.
31. Barry JL, Hoebler C, Macfarlane GT, Macfarlane S, Mathers JC, Reed KA, et al. Estimation of the fermentability of dietary fibre in vitro: a European interlaboratory study. Br J Nutr 1995; 74:303-322.
32. Veress B, Lofberg R, Bergman L. Microscopic colitis syndrome. Gut 1995; 36:880-886.
33. Lee E, Schiller LR, Vendrell D, Santa Ana CA, Fordtran JS. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992; 103:1790-1796.
34. Zins BJ, Tremaine WJ, Carpenter HA. Collagenous colitis: mucosal biopsies and association with fecal leukocytes. Mayo Clin Proc 1995; 70:430-433.
35. Jessurun J, Giardiello FM, Hamilton SR, Bayless TM, Yardley JH. Collagenous colitis: a clinicopathologic study of 15 cases. Lab Invest 1986; 54:28A.
36. Lettesjisö H, Hansson T, Peterson C, Ung KA, Ringström G, Abrahamsson H, et al. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol 2005; 41:54-59.
37. Ramakrishna BS, Mathan VI. Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids. Gut 1993; 34:1215-1218.
38. Mortensen PB, Hove H, Clausen MR, Holtug K. Fermentation to short-chain fatty acids and lactate in human faecal batch cultures. Intra- and inter-individual variations versus variations caused by changes in fermented saccharides. Scand J Gastroenterol 1991; 26:1285-1294.
39. Mortensen PB, Holtug K, Bonnen H, Clausen MR. The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology 1990; 98:353-360.
40. Mortensen PB, Clausen MR, Bonnen H, Hove H, Holtug K. Colonic fermentation of ispaghula, wheat bran, glucose, and albumin to short-chain fatty acids and ammonia evaluated in vitro in 50 subjects. JPEN J Parenter Enteral Nutr 1992; 16:433-439.
41. Degen LP, Phillips SF. How well does stool form reflect colonic transit? Gut 1996; 39:109-113.
42. Wildt S, Madsen JL, Rumessen J. Small bowel permeability in collagenous colitis. Scand J Gastroenterol 2006; 41:1044-1049.
43. Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci 2006; 51:147-153.